THE Federal Court of Australia has
found that weight loss company
SensaSlim Australia Pty Ltd, now in
liquidation, engaged in misleading
or deceptive conduct by failing to
disclose Peter Foster’s involvement
in its franchise system’s disclosure
document.
The Court also found that the
company engaged in misleading
conduct with regards to the role of
SensaSlim’s officers, Peter O’Brien
and Michael Boyle, the “worldwide
clinical trial” of the solution and the
earning potential of its franchises.
Justice Yates described Foster
as a puppeteer in his judgement,
and said the failure to disclose his
involvement was deliberate.
The Australian Competition &
Consumer Commission started
proceedings against the company in
July 2011.
To read more, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Apr 14
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.